Salivary ZG16B expression loss follows exocrine gland dysfunction related to oral chronic graft-versus-host disease Journal Articles uri icon

  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All


  • Chronic graft-versus-host disease (cGVHD) targets include the oral mucosa and salivary glands after allogeneic hematopoietic stem cell transplant (HSCT). Without incisional biopsy, no diagnostic test exists to confirm oral cGVHD. Consequently, therapy is often withheld until severe manifestations develop. This proteomic study examined saliva and human salivary gland for a biomarker profile at first onset of oral cGVHD prior to initiation of topical steroid therapy. Whole saliva collected at onset of biopsy-proven oral GVHD was assessed using liquid chromatography-coupled tandem mass spectrometry with identification of 569 proteins, of which 77 significantly changed in abundance. ZG16B, a secretory lectin protein, was reduced 2-fold in oral cGVHD saliva (p <0.05), and significantly decreased in salivary gland secretory cells affected by cGVHD. Single-cell RNA-seq analysis of healthy MSG localized ZG16B expression to two discrete acinar cell populations. Reduced ZG16B expression may indicate specific cGVHD activity and possibly general salivary gland dysfunction.


  • Costa-da-Silva, Ana Caroline
  • Aure, Marit H
  • Dodge, Joshua
  • Martin, Daniel
  • Dhamala, Susan
  • Cho, Monica
  • Rose, Jeremy J
  • Bassim, Carol Walker
  • Ambatipudi, Kiran
  • Hakim, Frances T
  • Pavletic, Steven Z
  • Mays, Jacqueline W

publication date

  • January 2022